This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Safer, D. J.
Right arrow Articles by Malever, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Safer, D. J.
Right arrow Articles by Malever, M.
Related Collections
Right arrow Therapeutics & Toxicology

PEDIATRICS Vol. 106 No. 3 September 2000, pp. 533-539

Stimulant Treatment in Maryland Public Schools

Received Jul 29, 1999; accepted Jan 7, 2000.

Daniel J. Safer* and Michael MaleverDagger

From the * Departments of Psychiatry and Pediatrics, Johns Hopkins Medical Institutions, and the Dagger  Maryland State Department of Education, Baltimore, Maryland.

Objective.  A statewide school survey was performed to provide naturalistic data on the prevalence of medication administered to Maryland public school students for the treatment of attention deficit hyperactivity disorder (ADHD) to clarify the concern of some state legislators about stimulant treatment for youths.

Methods.  In April 1998, school nurses supervised a survey of all Maryland public school students medicated during school hours for ADHD. The data collected on these students included: type of medication administered, gender, school level, race/ethnicity, special education and Section 504 status, and the specialist of the prescriber.

Results.  Of the 816 465 students surveyed, 20 050 (2.46%) received methylphenidate and 3721 (0.46%) received other medications for ADHD. Other major findings were: 1) methylphenidate constituted 84% of all the medication administered for ADHD; 2) the male:female ratio of the medication's recipients was 3.5:1 and 4.3:1 in elementary and secondary school, respectively; 3) black and Hispanic students received methylphenidate at approximately half the rate of their white counterparts; 4) 45% of all students receiving methylphenidate had special education status and an additional 8% had Section 504 status; and 5) nurse practitioners were the prescribers of 3% of the methylphenidate prescribed to Maryland students.

Conclusions.  This large, population-based, point prevalence study of medication administered to students for ADHD adds new and updated findings on prevalence variations, rates for minority and special education/Section 504 students, and specialty prescriber rates.  Key words:  attention deficit hyperactivity disorder, methylphenidate, stimulant medication, pharmacoepidemiology.




This article has been cited by other articles:


Home page
 Journal of Emotional and Behavioral DisordersHome page
L. K. Leslie, K. M. Lambros, G. A. Aarons, R. A. Haine, and R. L. Hough
School-Based Service Use by Youth With ADHD in Public-Sector Settings
Journal of Emotional and Behavioral Disorders, September 1, 2008; 16(3): 163 - 177.
[Abstract] [PDF]

Home page
 Remedial and Special EducationHome page
J. B. Ryan, R. Reid, and C. Ellis
Special Educators' Knowledge Regarding Psychotropic Interventions for Students With Emotional and Behavioral Disorders
Remedial and Special Education, September 1, 2008; 29(5): 269 - 279.
[Abstract] [PDF]

Home page
 NASSP BulletinHome page
R. A. Holler and P. A. Zirkel
Section 504 and Public Schools: A National Survey Concerning "Section 504-Only" Students
NASSP Bulletin, March 1, 2008; 92(1): 19 - 43.
[Abstract] [PDF]

Home page
 The Journal of School NursingHome page
R. L. DuPont, R. H. Bucher, B. B. Wilford, and J. J. Coleman
School-Based Administration of ADHD Drugs Decline, Along With Diversion, Theft, and Misuse
The Journal of School Nursing, December 1, 2007; 23(6): 349 - 352.
[Abstract] [PDF]

Home page
 J Pediatr PsycholHome page
L. K. Leslie and M. L. Wolraich
ADHD Service Use Patterns in Youth
J. Pediatr. Psychol., July 1, 2007; 32(6): 695 - 710.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Emotional and Behavioral DisordersHome page
L. K. Leslie, G. Canino, J. Landsverk, P. A. Wood, L. Chavez, R. L. Hough, J. J. Bauermeister, and R. Ramirez
ADHD Treatment Patterns of Youth Served in Public Sectors in San Diego and Puerto Rico
Journal of Emotional and Behavioral Disorders, January 1, 2005; 13(4): 224 - 236.
[Abstract] [PDF]

Home page
 PediatricsHome page
D. A. Christakis, F. J. Zimmerman, D. L. DiGiuseppe, and C. A. McCarty
Early Television Exposure and Subsequent Attentional Problems in Children
Pediatrics, April 1, 2004; 113(4): 708 - 713.
[Abstract] [Full Text] [PDF]

Home page
 The Journal of School NursingHome page
A. Kwasman, B. Tinsley, and S. Thompson
School Nurses' Knowledge and Beliefs About the Management of Children With ADD
The Journal of School Nursing, February 1, 2004; 20(1): 22 - 28.
[Abstract] [PDF]

Home page
 CLIN PEDIATRHome page
E. H. Harel and W. D. Brown
Attention Deficit Hyperactivity Disorder in Elementary School Children in Rhode Island: Associated Psychosocial Factors and Medications Used
Clinical Pediatrics, July 1, 2003; 42(6): 497 - 503.
[Abstract] [PDF]

Home page
 Am. J. PsychiatryHome page
M. Olfson, M. J. Gameroff, S. C. Marcus, and P. S. Jensen
National Trends in the Treatment of Attention Deficit Hyperactivity Disorder
Am J Psychiatry, June 1, 2003; 160(6): 1071 - 1077.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
E. R. Cox, B. R. Motheral, R. R. Henderson, and D. Mager
Geographic Variation in the Prevalence of Stimulant Medication Use Among Children 5 to 14 Years Old: Results From a Commercially Insured US Sample
Pediatrics, February 1, 2003; 111(2): 237 - 243.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
R. A. Barkley, M. Fischer, L. Smallish, and K. Fletcher
Does the Treatment of Attention-Deficit/Hyperactivity Disorder With Stimulants Contribute to Drug Use/Abuse? A 13-Year Prospective Study
Pediatrics, January 1, 2003; 111(1): 97 - 109.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
M. Olfson, S. C. Marcus, B. Druss, and H. A. Pincus
National Trends in the Use of Outpatient Psychotherapy
Am J Psychiatry, November 1, 2002; 159(11): 1914 - 1920.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
D. A. Kube, M. C. Petersen, and F. B. Palmer
Attention Deficit Hyperactivity Disorder: Comorbidity and Medication Use
Clinical Pediatrics, September 1, 2002; 41(7): 461 - 469.
[Abstract] [PDF]

Home page
 PediatricsHome page
J. Guevara, P. Lozano, T. Wickizer, L. Mell, and H. Gephart
Psychotropic Medication Use in a Population of Children Who Have Attention-Deficit/Hyperactivity Disorder
Pediatrics, May 1, 2002; 109(5): 733 - 739.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Public HealthHome page
A. S. Rowland, D. M. Umbach, L. Stallone, A. J. Naftel, E. M. Bohlig, and D. P. Sandler
Prevalence of Medication Treatment for Attention Deficit-Hyperactivity Disorder Among Elementary School Children in Johnston County, North Carolina
Am J Public Health, February 1, 2002; 92(2): 231 - 234.
[Abstract] [Full Text] [PDF]